HCPLive Network

NSAIDs Exacerbate Exercise-Induced Small Intestinal Injury

WEDNESDAY, Dec. 12 (HealthDay News) -- Nonsteroidal anti-inflammatory drugs (NSAIDs) aggravate exercise-induced small intestinal injury in athletes, according to a study published in the December issue of Medicine & Science in Sports & Exercise.

Kim van Wijck, M.D., from the Maastricht University Medical Center in the Netherlands, and colleagues studied nine healthy, trained men under four conditions: 400 mg ibuprofen twice before cycling; cycling without ibuprofen; 400 mg ibuprofen twice at rest; and rest without ibuprofen intake. Plasma intestinal fatty acid binding protein (I-FABP) levels were used to assess small intestinal injury. Liquid chromatography and mass spectrometry were used to measure urinary excretion of orally ingested multi-sugar test probes to assess gastrointestinal permeability.

The researchers observed increased I-FABP levels with both ibuprofen consumption and cycling, indicative of small intestinal injury. Levels were highest after cycling with ibuprofen versus cycling without ibuprofen and rest with or without ibuprofen. Small intestinal permeability increased, particularly after cycling with ibuprofen, indicative of gut barrier integrity loss. There was a significant correlation between the extent of intestinal injury and barrier dysfunction.

"The current study shows that, in healthy endurance athletes, NSAID consumption can aggravate exercise-induced small intestinal injury and induces loss of gut barrier function," the authors write. "We consider it of utmost importance to increase the awareness of athletes and trainers toward the potential negative effects of NSAIDs and recommend that the use of NSAIDs in the absence of a clear medical indication should be discouraged."

Full Text

Copyright © 2012 HealthDay. All rights reserved.

Further Reading
The financial burden of caring for patients with chronic low back pain (CLBP) in the United Kingdom is twice that of caring for patients without CLBP, according to a study published in the Jan. 1 issue of Spine.
There appears to be no association between persistent pulmonary hypertension of the newborn and gestational exposure to nonsteroidal anti-inflammatory drugs, including ibuprofen, according to a study published online Dec. 3 in Pediatrics.
The leukocyte adhesion protein E-selectin is an inflammatory biomarker in the pathogenesis of lumbar disc herniation, according to a study published in the December issue of the Journal of Spinal Disorders & Techniques.
Traditional NSAIDs and second-generation NSAIDs (cyclooxygenase-2 inhibitors) are commonly prescribed treatments for a wide range of painful conditions, including acute pain, low back pain, headache, rheumatoid arthritis, and osteoarthritis. However, these medications are also associated with serious gastrointestinal complications and other adverse events.
Analysis of claims data finds patients often receive starting doses of Butrans that do not follow published recommendations, with more than one-third of patients receiving initial doses that are too low.
According to a recent systematic review, the prescient and short-term use of NSAIDs and opioids with pharmacological sensitivity to an individual’s comorbidities may result in pain relief, improved functioning, and reduced vocational and avocational absenteeism.
With most medical schools devoting only a few curriculum hours to pain management training, many physicians begin their medical career underprepared to meet the needs of patients suffering with chronic pain. Here, Barry Cole, MD, identifies several key concepts that would help improve pain care in the US if only more physicians would learn about them sooner.
More Reading